🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a global, multi-centre, open-label, study of GSK2118436 conducted i...
Status
Terminated
Location
GSK Investigational Site
Start Date
2014-04-08
Trial ID
NCT01978236
Treatments Being Tested
The study is designed to evaluate the effects of a high fat meal on the pha...
Status
Completed
Location
GSK Investigational Site
Start Date
2010-10-21
Trial ID
NCT01231568
Present clinical study will be conducted in China to evaluate the pharmacok...
Status
Withdrawn
Location
Multiple Locations
Start Date
2017-05
Trial ID
NCT02447939
Treatments Being Tested
This is an open-label, multi-center, fixed sequence study in subjects with ...
Status
Completed
Location
GSK Investigational Site
Start Date
2015-02-19
Trial ID
NCT02082665
Treatments Being Tested
Subjects with papillary craniopharyngioma harboring a BRAF mutation will be...
Status
Recruiting
Location
Department of Endocrinology
Start Date
2023-09-01
Trial ID
NCT05525273
Treatments Being Tested
This was a two-arm, randomized, double-blind Phase III study of dabrafenib ...
Status
Completed
Location
Novartis Investigative Site
Start Date
2013-01-08
Trial ID
NCT01682083
Treatments Being Tested
This is a multi-cohort, open label, Phase II study with Dabrafenib (GSK2118...
Status
Completed
Location
Novartis Investigative Site
Start Date
2014-02-21
Trial ID
NCT02039947
Treatments Being Tested
This is a Phase 1 study of E6201 plus dabrafenib for the treatment of CNS m...
Status
Terminated
Location
University of Arizona Cancer Center
Start Date
2018-07-02
Trial ID
NCT03332589
Treatments Being Tested
This is a prospective interventional trial that aims to restore iodine inco...
Status
Unknown
Location
Manuel M. Weber
Start Date
2018-02-05
Trial ID
NCT04619316
Treatments Being Tested
This is a Phase I, multicenter, 2-part study with Part 1 designed as a safe...
Status
Completed
Location
GSK Investigational Site
Start Date
2013-01-22
Trial ID
NCT01738451
Treatments Being Tested